RECRUITING

Lemborexant Treatment of Insomnia Linked to Epilepsy

Description

The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.

Conditions

EpilepsySleep
Talk to us

Related Conditions:

EpilepsySleep

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.

Lemborexant Treatment of Insomnia Linked to Epilepsy

Lemborexant Treatment of Insomnia Linked to Epilepsy

Condition
Epilepsy
Intervention / Treatment

-

Contacts and Locations

Durham

Duke University, Durham, North Carolina, United States, 27708

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Sleep-related focal epilepsy
  • * Contraception
  • * Changes in antiseizure medication 1 month before study protocol or during study protocol
  • * Concomitant medications per SUNRISE1
  • * Individuals with hepatic impairment
  • * Female participants who are pregnant or breastfeeding
  • * Individuals with compromised respiratory function
  • * Individuals with a history of complex sleep-related behaviour
  • * Individuals with rare hereditary diseases of galactose intolerance such as galactosemia or glucose-galactose malabsorption
  • * Individuals with a history of dependence or tolerance - abuse, dependence, rebound insomnia
  • * Individuals with psychiatric disorders with abnormal thinking and behavioural changes, depression, or suicidal ideation
  • * Individuals with a diagnosis of narcolepsy

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Manitoba,

Study Record Dates

2027-04-18